본문 바로가기

Business

Project Overview & Procedure

Welcome to the Daegu-Gyeongbuk Medical Cluster, the future of the global medical industry!

OASIS Project (company support program)

※ Open-Analysis, Solid and Infection drug Serviec

  • Much like an oasis in the middle of a desert, the OASIS Project aims to quench companies’ thirst for the technologies they need to further their business endeavors.

Scope of Support

  • Non-clinical trials
  • Investigational new drug application (IND)
  • Clinical trials (Phase I-III)
  • New drug application (NDA)
  • Permission/sales
  • Manufact
    uring
    • Manufacture and supply of medicine and medical supplies (drug products and pharmaceutical ingredients)
    • Process development
    • Formulation study
  • Analysis
    • Support for the development of analytical methods
    • Stability testing (determination of expiration dates and retest periods, conducting of on-going stability tests)
    • Quality control (QC)
    • Chemistry, manufacturing, and control (CMC) support

Areas of Support

Support for the manufacturing of medicine and medical supplies

  • Contract manufacturing of R&D medicine and medical supplies, joint utilization of facilities
Scope of Support
Scope of Support
Category
Solids (except cytotoxic drugs)   View PDF Tablets (single/multi-layered tablets)
Capsules
Injections (cytotoxic drugs)   View PDF Liquids Vials (6 ml, 15R, 20R, etc.)
Freeze-dried drugs
Pharmaceutical ingredients
(except cytotoxic drugs)   View PDF
Reactors (10L, 100L, and 150L)

Analysis Support

  • Support for the analysis of ingredients and drug products in the development stage, development of analytical methods, validation, and stability testing
Scope of Support
  • Development of analytical methods, stability testing, lot release tests, etc.

GMP consulting, support for permits/licensing

  • Provision of consultations for GMP facilities and the manufacture and analysis of drugs, support for filing permit/licensing applications and monitoring the progress of these applications
Scope of Support
  • Drug production and processing, analysis techniques, environmental health and safety (EH&S), establishment, operation, and management of GMP facilities, investigational new drug application (IND), new drug application (NDA), etc.
Support Procedure
지원절차로 의뢰자는 위탁처 고객으로 임상시험신약생산센터로 의뢰요청 및 의뢰요청서를 작성하여 접수하고 부서별 검토(생산팀, QC팀, QA팀)하여 기능여부 회신 되면 산출내역 회신을 8일이내로 고객승인을 거쳐 업무협의후 계약서 작성하고 계약체결 후 업무수행을 합니다. 기능여부 회신이 불가능 할경우 의뢰자에게 다시 반송한다.

※ To make an inquiry, please fill out the inquiry form on our website (www.dgmif.re.kr), and contact us by either phone or email.
(Tel) +82-53-790-5877 (E-mail) cdmc@dgmif.re.kr

Professional Personnel Development Project

Purpose

To provide GMP training and practical training for students of pharmaceutical science programs and employees of organizations related to the pharmaceutical industry through the use of the facilities, equipment, and human resources at the Clinical Drug Manufacturing Center

Eligibility

  • Employees of organizations related to the pharmaceutical industry
  • Students in pharmaceutical science programs

Training Areas

  • Production of medicine and medical supplies, such as solids, injections, and pharmaceutical ingredients
  • Quality control and assessment
  • Management and operation of GMP facilities

(Tel) +82-53-790-5877